Alumis
Latest round
- Series C
Last raised
- Mar 2024
Total raised
- $192M
Investors
- 12
About Alumis
, formely known as Esker Therapeutics Inc. operates as a precision medicine company that focuses on the discovery, development, and treatment of autoimmune disorders. In March 2024, Alumis Inc. Esker Therapeutics is a Foresite Labs-incubated precision medicine company that is reworking the discovery, development, and treatment of autoimmune disorders and comprises curated genetic, clinical, and health records data, a systems immunology toolkit for prospective data collection, and tools for building patient registries. The company's pipeline, ESK-001, also known as a TYK2 inhibitor, is currently in clinical development for psoriasis with multiple other indications. TYK2 is a gene that encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families and a central node in the signalling pathways of cytokines known as key mediators of inflammation and autoimmune diseases.
Who invested in Alumis
12 investors across 2 rounds
See all investors in Alumis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alumis
Who invested in Alumis?
Alumis has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alumis raised?
Alumis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alumis last raise money?
Alumis's most recent round on record is a Series C, in Mar 2024.
What does Alumis do?
, formely known as Esker Therapeutics Inc.
Where is Alumis headquartered?
Alumis is headquartered in South San Francisco, US.
Which VCs invest in companies like Alumis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alumis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Alumis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.